在默克尔细胞癌中预后不佳的基因组特征:单一机构前性研究
Joshua D Smith1, Apurva D Bhangale2, Wenjin Gu3
1UPMC Health System, United States.
Molecular cancer research : MCR
|July 21, 2025
概括
默克尔细胞癌 (MCC) 的存活率可以通过结合瘤突变负担和拷贝数变化的新基因组学得分来预测. 这一分数为这种侵袭性癌症的预后标志物和瘤发生机制提供了关键的见解.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 病毒学 病毒学
背景情况:
- 默克尔细胞癌 (MCC) 是一种侵袭性癌症,发病率不断上升,生存率不佳.
- 了解MCC瘤发生和识别预测性遗传特征对于改善患者的治疗结果至关重要.
- 需要新的生物信息学工具来分析默克尔细胞多重瘤病毒 (MCPyV) -宿主基因组相互作用.
研究的目的:
- 为了研究MCC瘤的遗传景观.
- 开发和验证用于分析MCPyV集成的信息工具.
- 评估遗传特征对MCC生存的预后影响.
主要方法:
- 整体外基因组测序和226个基因组对54个MCC瘤的分析.
- 开发用于MCPyV集成站点分析的MCPyViewer信息包.
- 对遗传特征的分析及其与MCC特异性生存率的相关性.
主要成果:
- 高频变异的人类基因包括LRP1B,FAT1,KMT2D和RB1.1.
- 在81.8%的MCPyV阳性瘤中发现了MCPyV集成,每种瘤中均有2个事件.
- 综合基因组学得分 (瘤突变负担和拷贝数变异) 对MCC特异性生存有很强的预后.
结论:
- 一个包含瘤突变负担和拷贝数变化的新型基因组学评分作为MCC特异性生存的强有力的预后标志物.
- 这项研究增强了对MCC的预后标志物和瘤发生机制的理解.
- 开发的MCPyViewer工具为研究人员简化了MCPyV集成站点分析.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K